Loading…
Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases
vitamin D is 25-hydroxylated in the liver, before being activated by 1α-hydroxylation in the kidney. Recently, the rat cytochrome P450 2J3 (CYP2J3) has been identified as a principal vitamin D 25-hydroxylase in the rat [Yamasaki T, Izumi S, Ide H, Ohyama Y. Identification of a novel rat microsomal v...
Saved in:
Published in: | Steroids 2006-10, Vol.71 (10), p.849-856 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | vitamin D is 25-hydroxylated in the liver, before being activated by 1α-hydroxylation in the kidney. Recently, the rat cytochrome P450 2J3 (CYP2J3) has been identified as a principal vitamin D 25-hydroxylase in the rat [Yamasaki T, Izumi S, Ide H, Ohyama Y. Identification of a novel rat microsomal vitamin D
3 25-hydroxylase. J Biol Chem 2004;279(22):22848–56]. In this study, we examine whether human CYP2J2 that exhibits 73% amino acid homology to rat CYP2J3 has similar catalytic properties. Recombinant human CYP2J2 was overexpressed in
Escherichia coli, purified, and assayed for vitamin D 25-hydroxylation activity. We found significant 25-hydroxylation activity toward vitamin D
3 (turnover number, 0.087
min
−1), vitamin D
2 (0.16
min
−1), and 1α-hydroxyvitamin D
3 (2.2
min
−1). Interestingly, human CYP2J2 hydroxylated vitamin D
2, an exogenous vitamin D, at a higher rate than it did vitamin D
3, an endogenous vitamin D, whereas, rat CYP2J3 hydroxylated vitamin D
3 (1.4
min
−1) more efficiently than vitamin D
2 (0.86
min
−1). Our study demonstrated that human CYP2J2 exhibits 25-hydroxylation activity as well as rat CYP2J3, although the activity of human CYP2J2 is weaker than rat CYP2J3. CYP2J2 and CYP2J3 exhibit distinct preferences toward vitamin D
3 and D
2. |
---|---|
ISSN: | 0039-128X 1878-5867 |
DOI: | 10.1016/j.steroids.2006.04.009 |